Release Date: 30/09/16 14:06 Summary: Annual Report to shareholders-ILH.AX Price Sensitive: No Download Document 1.96MB Download
MSB Mesoblast resubmits US FDA application for approval of Ryoncil in children with graft vs host disease; shares dip -4%